產(chǎn)品名稱

PKG drug G1

產(chǎn)品貨號(hào)

Axon 2232 CAS [374703-78-3] MF C13H11N3OSMW 257.31 Purity: 99% Soluble in DMSO Description PKG drug G1 has been shown to induce the oxidative activation of protein kinase G Iα, which in vivo results in dilation of blood vessel and blood pressure lowering; an antihypertensive. The sodium salt form is also available as Axon 2905. * Developed and sold in collaboration with KCL (King's College of London). KEYWORDS: PKG drug G1 | supplier | PKG Iα inducer | CAS [374703-78-3] | Non Selective (Phosphorylation Substrates) | PKG | Inducer | Enzymes | Antihypertension

產(chǎn)品價(jià)格

現(xiàn)貨詢價(jià)，電話：010-67529703

產(chǎn)品規(guī)格

產(chǎn)品品牌

axonmedchem

產(chǎn)品概述

產(chǎn)品詳情

PKG drug G1

Based on 1 reference(s) in Google Scholar 8 10 1

Axon 2232

CAS [374703-78-3]

MF C13H11N3OS
MW 257.31

Purity: 99%
Soluble in DMSO

PKG drug G1

Description

PKG drug G1 has been shown to induce the oxidative activation of protein kinase G Iα, which in vivo results in dilation of blood vessel and blood pressure lowering; an antihypertensive.

The sodium salt form is also available as Axon 2905.

* Developed and sold in collaboration with KCL (King's College of London).

JR Burgoyne et al. Proof of Principle for a Novel Class of Antihypertensives That Target the Oxidative Activation of PKG Iα (Protein Kinase G Iα). Hypertension. 2017 Sep;70(3):577-586.

Certificate of Analysis
Material Safety Data Sheet

Cardiovascular PKG 2.7.11.12

Inducer of oxidative activation of protein kinase G Iα

Chemical name

5-((2-Methyl-1H-indol-3-yl)methylene)-2-thioxoimidazolidin-4-one

Parent CAS No.

[374703-78-3]

產(chǎn)品資料